Online citations, reference lists, and bibliographies.
← Back to Search

Nanoparticles--a Historical Perspective.

J. Kreuter
Published 2007 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The historical development of nanoparticles starting with Paul Ehrlich and then first attempts by Ursula Scheffel and colleagues and the extensive work by the group of Professor Peter Speiser at the ETH Zürich in the late 1960s and early 1970s are described from a personal point of view. Special attention is given to the years between 1970 and the early 1980s. Further developments resulting from this work are also followed, and focus is placed on especially interesting improvements such as nanoparticles for the delivery of drugs across the blood-brain barrier (BBB) and PEGylated nanoparticles with a prolonged blood circulation time.
This paper references
10.1016/0378-5173(83)90113-8
Physicochemical characterization of polyacrylic nanoparticles
J. Kreuter (1983)
10.1016/S0378-4274(01)00456-8
Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.
S. Gelperina (2002)
10.3929/ETHZ-A-000131806
Charakterisierung, Anwendung und Eignung der Nanokapsulierung auf Acrylamid Basis zur Einhüllung niedermolekularer Arzneistoffe
H. Kopf (1975)
10.1002/JPS.2600631044
Letter: Albumin microspheres as vehicles for achieving specificity in drug delivery.
P. Kramer (1974)
10.1016/0277-5379(83)90409-1
Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere disposition.
K. Widder (1983)
10.1002/POL.1982.130201006
On the mechanism of termination in heterogeneous polymerization
J. Kreuter (1982)
10.1016/0014-5793(77)80717-5
Nanocapsules: A new type of lysosomotropic carrier
P. Couvreur (1977)
10.1002/JPS.2600840420
Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.
D. Bazile (1995)
10.1002/ijc.20048
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
S. C. Steiniger (2004)
10.1016/0378-5173(83)90166-7
Pharmacokinetics and Distribution of a Biodegradable Drug-carrier
L. Grislain (1983)
10.1016/S0168-3659(99)00063-2
Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting.
M. Peracchia (1999)
10.1139/Y80-030
Preparation and properties of poly(Nα,Nε-L-lysinediylterephthaloyl) microcapsules containing hemolysate in the nanometer range
M. Arakawa (1980)
10.1007/BF02169795
Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles)
R. Diepold (2005)
10.1080/10611860290031877
Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier
J. Kreuter (2002)
10.1007/978-1-4612-5182-8_30
Preparation and In Vivo Studies of a New Drug Delivery System
P. Maincent (1984)
10.1002/JPS.2600730934
Distribution and elimination of polymethyl methacrylate nanoparticles after peroral administration to rats.
M. Nefzger (1984)
10.1089/AID.1996.12.1709
Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy.
R. Löbenberg (1996)
10.2337/diab.37.2.246
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
10.1016/J.BIOMATERIALS.2004.07.047
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.
S. Balthasar (2005)
10.1002/JPS.2600720933
Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration.
S. Illum (1983)
10.1089/SCT.1989.5.1
Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases.
N. Chiannilkulchai (1989)
10.1111/j.2042-7158.1979.tb13510.x
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties
P. Couvreur (1979)
10.1016/J.JCONREL.2004.07.019
Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model.
I. Brigger (2004)
10.1002/JPS.2600751009
Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.
P. Maincent (1986)
10.1002/JPS.2600580916
Epoxy resin beads as a pharmaceutical dosage form. I. Method of preparation.
S. C. Khanna (1969)
10.3109/02652049209021219
Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles.
S. Tröster (1992)
Nanoparticles--a new colloidal drug delivery system.
J. Marty (1978)
10.1124/jpet.105.097139
Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain
K. Michaelis (2006)
10.1021/IE50705A006
SURFACE CHEMISTRY ASPECTS OF EMULSION POLYMERIZATION
Charles P. Roe (1968)
10.1046/j.1460-9568.2000.00078.x
Polysorbate‐80 coating enhances uptake of polybutylcyanoacrylate (PBCA)‐nanoparticles by human and bovine primary brain capillary endothelial cells
P. Ramge (2000)
Biodegradable microspheres II: Immune response to a heterologous and an autologous protein entrapped in polyacryl starch microparticles.
P. Artursson (1985)
10.1201/b19309
Encyclopedia of Pharmaceutical Technology
J. Swarbrick (2006)
Preliminary study of prolonged acting drug delivery system for the treatment of glaucoma.
R. Gurny (1981)
Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles
R. Alyautdin (1995)
10.1128/AAC.32.8.1204
Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice.
M. Youssef (1988)
10.1016/0378-5173(86)90053-0
Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles
T. Harmia (1986)
10.1002/JPS.2600590508
Bead polymerization technique for sustained-release dosage form.
S. C. Khanna (1970)
10.1016/0378-5173(90)90047-8
Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants
S. Tröster (1990)
10.1016/0378-5173(81)90100-9
Solid colloidal drug delivery systems: Nanoparticles
R. Oppenheim (1981)
10.1201/9781498710565
Colloidal Drug Delivery Systems
J. Kreuter (1994)
10.1007/BF02122746
Protection induced by inactivated influenza virus vaccines with polymethylmethacrylate adjuvants
J. Kreuter (2005)
10.1007/BF02783760
Preparation and in vivo studies of a new drug delivery system
P. Maincent (1984)
10.1248/bpb1978.2.350
DRUG-CARRIER PROPERTY OF ALBUMIN MICROSPHERES IN CHEMOTHERAPY. III. EFFECT OF MICROSPHERE-ENTRAPPED 5-FLUOROURACIL ON EHRLICH ASCITES CARCINOMA IN MICE
K. Sugibayashi (1979)
10.1002/JPS.2600710717
Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles.
P. Couvreur (1982)
10.1002/JPS.2600620910
Preparation and in vitro evaluation of cellulose acetate phthalate coacervate microcapsules.
H. P. Merkle (1973)
Nanoparticles and nanocapsules--new dosage forms in the nanometer size range.
J. Kreuter (1978)
10.1080/00337577808240836
The use of 60Co-γ-irradiation for the production of vaccines
J. Kreuter (1978)
10.1021/BI00668A026
Incorporation of macromolecules in microparticles: preparation and characteristics.
B. Ekman (1976)
10.1002/JPS.2600651115
In vitro studies of poly(methyl methacrylate) adjuvants.
J. Kreuter (1976)
10.1016/J.JCONREL.2004.01.029
Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles.
Heidrun Wartlick (2004)
10.1016/0006-8993(95)00023-J
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
J. Kreuter (1995)
10.1023/A:1012098005098
Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles
R. Alyautdin (2004)
10.1016/0378-5173(87)90080-9
Attachment of antibiotics to nanoparticles: preparation, drug-release and antimicrobial activity in vitro
S. Henry-Michelland (1987)
10.1248/CPB.27.204
Drug-carrier property of albumin microspheres in chemotherapy. II. Preparation and tissue distribution in mice of microsphere-entrapped 5-fluorouracil.
K. Sugibayashi (1979)
10.1080/10611860400010697
Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells
Heidrun Wartlick (2004)
10.1016/S0939-6411(00)00068-0
Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid.
K. Langer (2000)
10.1016/0378-5173(86)90236-X
Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules
N. A. K. Fallouh (1986)
10.3929/ETHZ-A-000184495
Neue Adjuvantien auf Polymethylmethacrylatbasis
Jörg Kreuter (1974)
10.1002/JPS.2600731103
Characterization of polyacryl starch microparticles as carriers for proteins and drugs.
P. Artursson (1984)
10.1016/0024-3205(87)90138-X
The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.
L. Illum (1987)
10.1016/S0168-3659(97)00105-3
Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats.
R. Löbenberg (1998)
Tumoritropic and lymphotropic principles of macromolecular drugs.
H. Maeda (1989)
10.1016/0378-5173(94)90372-7
Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers
Gerrit Borchard (1994)
10.1159/000162849
The use of new polymethylmethacrylate adjuvants for split influenza vaccines.
J. Kreuter (1976)
10.1016/0277-5379(83)90408-X
Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
K. Widder (1983)
10.1002/JPS.2600690725
Immobilization of proteins in microspheres of biodegradable polyacryldextran.
P. Edman (1980)
10.3929/ETHZ-A-000131801
Ueber Mizellpolymerisate, mögliche Einschlussverbindungen(Nanokapseln) und deren Eignung als Adjuvantien
G. Birrenbach (1973)
10.1016/0014-2964(80)90053-5
Actinomycin D absorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor.
F. Brasseur (1980)
10.1023/A:1018983904537
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
A. Gulyaev (2004)
10.1002/JPS.2600651217
Polymerized micelles and their use as adjuvants in immunology.
G. Birrenbach (1976)
10.1128/AAC.33.9.1540
Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles.
E. Fattal (1989)
10.1126/SCIENCE.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
10.1111/J.1470-8744.1991.TB00160.X
Use of liposomes, viral capsids, and nanoparticles as DNA carriers
W.M. Bertling (1991)
10.1124/jpet.102.039669
Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting
I. Brigger (2002)
10.1128/IAI.13.1.204-210.1976
New adjuvants on a polymethylmethacrylate base.
J. Kreuter (1976)
10.1002/JPS.2600680124
Magnetic microspheres: synthesis of a novel parenteral drug carrier.
K. Widder (1979)
10.3109/02652049809006836
Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.
R. Alyautdin (1998)
10.1002/(SICI)1097-4636(19970305)34:3<317::AID-JBM6>3.0.CO;2-N
Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol).
M. Peracchia (1997)
10.3109/03639048109055684
Development of Biodegradable and Injectable Latices for Controlled Release of Potent Drugs
R. Gurny (1981)
10.1080/026520400288427
Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake.
C. Coester (2000)
Albumin microspheres for study of the reticuloendothelial system.
U. Scheffel (1972)
10.1007/BF00877245
Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles
J. Kattan (2004)
10.1023/A:1015871809313
Polyalkylcyanoacrylate Nanoparticles as Polymeric Carriers for Antisense Oligonucleotides
C. Chavany (2004)
10.1248/CPB.25.3433
Drug-carrier property of albumin microspheres in chemotherapy. I. Tissue distribution of microsphere-entrapped 5-fluorouracil in mice.
K. Sugibayashi (1977)
Improved peroral delivery of avarol with polybutylcyanoacrylate nanoparticles
P. Beck (1994)



This paper is referenced by
10.1016/j.vetimm.2012.06.002
An investigation into the potential use of nanoparticles as adjuvants for the production of polyclonal antibodies to low molecular weight compounds.
S. E. George (2012)
10.1007/s11051-017-3885-8
Is autocorrelation image analysis the proper method in nanoparticle sizing?
J. Marek (2017)
10.1007/978-1-4939-1417-3_10
Polymeric Particulates for Subunit Vaccine Delivery
Thomas B. Schuster (2015)
10.1201/B17191-4
Physicochemical Characterization–Dependent Toxicity of Nanoparticles
Jigar Shah (2014)
Magnetic nanoparticles: a new tool for antibiotic delivery to sinonasal tissues. Results of preliminary studies
K. Dobretsov (2015)
10.2217/fon.13.82
Preparation and characterization of gelatin nanoparticles containing pDNA encoding IL-12 and their expression in CT-26 carcinoma cells.
S. Hallaj-Nezhadi (2013)
10.2174/1568026615666150108145614
Recent advances in nanoparticle carriers for coordination complexes.
M. Sato (2015)
10.2147/IJN.S78547
Preparation of poly(β-L-malic acid)-based charge-conversional nanoconjugates for tumor-specific uptake and cellular delivery
Qing Zhou (2015)
10.1002/MASY.201450303
Cytotoxicity and Antioxidant Activity of Beta vulgaris Extract Released from Grafted Carbon Nanotubes Based Nanocomposites
Ahmed A. Haroun (2014)
CHAPTER 2-Nanoparticulate drug delivery systems and applications in the treatment of tuberculosis Abbreviations
()
10.1007/s11356-019-06459-2
Advances in nanomedical applications: diagnostic, therapeutic, immunization, and vaccine production
A. Elsayed (2019)
Preparation and Characterization of mPEG-PCL based Biodegradable Polymeric Nanoparticles for Anticancer Drugs Delivery
Samira Zaree (2017)
Nanoplasmonic biosensors for clinical diagnosis at the point of care
Maria Soler Aznar (2015)
10.1016/j.addr.2019.06.009
Careers in nanomedicine and drug delivery.
E. Nance (2019)
10.1016/J.TIBTECH.2007.09.005
Nanoparticles for drug delivery to the lungs.
Jean Sung (2007)
10.1007/s11596-016-1535-5
Multilayer Coating of Tetrandrine-loaded PLGA nanoparticles: Effect of surface charges on cellular uptake rate and drug release profile
R. Meng (2016)
10.2174/1381612822666161027111542
Polymer Nanoparticles as Smart Carriers for the Enhanced Release of Therapeutic Agents to the CNS.
M. Gagliardi (2017)
THESE DE L'UNIVERSITE DE LYON Délivrée par L'UNIVERSITE CLAUDE BERNARD LYON 1
École Doctorale (2010)
The effects of resveratrol encapsulated nanoparticles on viability of HT-29 colon cancer cells
C. G. Trotter (2014)
10.1080/1061186X.2018.1523418
Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics.
Fabiana de Sousa Cunha (2019)
10.1515/ntrev-2016-0009
Gelatin nanoparticles: a potential candidate for medical applications
Rehana Yasmin (2016)
10.3390/biom9020056
Formulations of Curcumin Nanoparticles for Brain Diseases
M. L. Del Prado-Audelo (2019)
10.31489/2018CH2/40-44
Preparation and characterization of empty nanoparticles of poly-D,L-lactic acid and serum albumin
Ye.M. Tazhbayev (2018)
10.31489/2019CH1/48-53
Albumin nanoparticles loaded with the antitumor drug «Hydroxycarbamide» by the incorporation method
Ye.M. Tazhbayev (2019)
10.1007/s00432-016-2179-3
Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy
Hadi Samadian (2016)
10.2147/IJN.S134526
Antibacterial properties and toxicity from metallic nanomaterials
Gina V Vimbela (2017)
10.3109/10837450.2014.965324
Formulation and characterization of clozapine and risperidone co-entrapped spray-dried PLGA nanoparticles
Apoorva Panda (2016)
10.1039/c1cs15188f
Toxicity of nanomaterials.
S. Sharifi (2012)
10.1016/J.CRHY.2011.06.001
Nanomedicine, Nanotechnology in medicine
P. Boisseau (2011)
Nanopartículas e suas aplicações em Ciências Farmacêuticas
N. Franco (2013)
10.2217/imt.11.5
Antibody-targeted nanoparticles for cancer therapy.
F. Fay (2011)
10.3390/ANTIB2020306
Single Domain Antibody Fragments as Drug Surrogates Targeting Protein–Protein Interactions inside Cells
T. H. Rabbitts (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar